About Magnolia Bark
Magnolia bark contains honokiol and magnolol, bioactive compounds that modulate GABA-A receptors. Preclinical evidence is promising but human RCTs for sleep are very limited. Emerging ingredient in sleep formulations. No established RDA/UL.
What Magnolia Bark supports
- May promote relaxation via GABA-A modulation
- Emerging evidence for sleep support, limited human data
How much Magnolia Bark to take
Clinical studies typically use 200β500 mg of Magnolia Bark. Standardized for honokiol/magnolol content; limited clinical dosing data.
- Effective range
- 200β500 mg
Clinical evidence
Limited clinical evidence. Promising preclinical GABA-A receptor data, but very limited human clinical trials for sleep
Examine.com